(KGL) Korporacja KGL S.A. - Ratings and Ratios
Plasticizers, Epoxy, Polyamines, Polyols, Additives
KGL EPS (Earnings per Share)
KGL Revenue
Description: KGL Korporacja KGL S.A.
Korporacja KGL S.A. (WAR:KGL) is a Polish specialty chemicals company, represented by its common stock. The companys market capitalization stands at 97.34M PLN, indicating a relatively small-cap entity. With a negative Return on Equity (RoE) of -5.92%, KGL is currently not generating returns for its shareholders, suggesting potential underlying operational or strategic issues.
From a valuation perspective, the absence of P/E and forward P/E ratios complicates the assessment of the companys valuation relative to its earnings. This is often the case when a company is not profitable or has negative earnings. To assess KGLs financial health, other KPIs such as debt-to-equity ratio, interest coverage ratio, and cash flow margins should be examined. Key economic drivers for specialty chemicals companies include raw material prices, demand from downstream industries (e.g., construction, automotive), and global supply chain dynamics.
The stocks price movements are characterized by a beta of 0.254, indicating relatively low volatility compared to the broader market. Over the past year, KGLs stock price has fluctuated between 12.19 and 15.08, with the current price standing at 13.80. The Average True Range (ATR) of 0.30 (or 2.17%) suggests moderate daily price movements. To further analyze the stocks potential, examining its trading volume, liquidity, and short interest could provide insights into market sentiment and potential price drivers.
Given the negative RoE and lack of P/E ratio, a thorough analysis of KGLs financial statements is necessary to understand the drivers behind these metrics. This includes examining revenue growth, gross margins, operating expenses, and cash flow generation. A deep dive into the companys operational efficiency, product portfolio, and competitive positioning within the specialty chemicals sector is also essential to assess its potential for future profitability and growth.
KGL Stock Overview
| Market Cap in USD | 27m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
KGL Stock Ratings
| Growth Rating | -17.9% |
| Fundamental | 44.2% |
| Dividend Rating | 71.9% |
| Return 12m vs S&P 500 | -23.5% |
| Analyst Rating | - |
KGL Dividends
| Dividend Yield 12m | 7.44% |
| Yield on Cost 5y | 6.41% |
| Annual Growth 5y | 8.02% |
| Payout Consistency | 63.1% |
| Payout Ratio | 44.0% |
KGL Growth Ratios
| Growth Correlation 3m | 13.3% |
| Growth Correlation 12m | -27.6% |
| Growth Correlation 5y | -10% |
| CAGR 5y | -3.03% |
| CAGR/Max DD 5y | -0.05 |
| Sharpe Ratio 12m | -0.12 |
| Alpha | -9.70 |
| Beta | -0.125 |
| Volatility | 51.28% |
| Current Volume | 0.4k |
| Average Volume 20d | 0k |
| Stop Loss | 12.9 (-3.7%) |
| Signal | -2.04 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-7.70m TTM) > 0 and > 6% of Revenue (6% = 31.5m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -9.99pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -2.08% (prev -1.74%; Δ -0.33pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 16.6m > Net Income -7.70m (YES >=105%, WARN >=100%) |
| Net Debt (130.3m) to EBITDA (33.3m) ratio: 3.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (7.05m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 13.96% (prev 17.79%; Δ -3.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 141.9% (prev 151.6%; Δ -9.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.34 (EBITDA TTM 33.3m / Interest Expense TTM 12.7m) >= 6 (WARN >= 3) |
Altman Z'' 1.08
| (A) -0.03 = (Total Current Assets 167.4m - Total Current Liabilities 178.3m) / Total Assets 375.7m |
| (B) 0.24 = Retained Earnings (Balance) 90.3m / Total Assets 375.7m |
| (C) 0.01 = EBIT TTM 4.27m / Avg Total Assets 369.9m |
| (D) 0.39 = Book Value of Equity 97.3m / Total Liabilities 248.4m |
| Total Rating: 1.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.18
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 4.29% = 2.14 |
| 3. FCF Margin 1.37% = 0.34 |
| 4. Debt/Equity 0.59 = 2.33 |
| 5. Debt/Ebitda 2.27 = -0.52 |
| 6. ROIC - WACC 2.05% = 2.56 |
| 7. RoE -5.92% = -0.99 |
| 8. Rev. Trend -84.11% = -4.21 |
| 9. Rev. CAGR -12.45% = -2.08 |
| 10. EPS Trend 3.76% = 0.09 |
| 11. EPS CAGR -37.54% = -2.50 |
What is the price of KGL shares?
Over the past week, the price has changed by -2.90%, over one month by -1.47%, over three months by -4.00% and over the past year by -10.56%.
Is Korporacja KGL S.A. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KGL is around 13.24 PLN . This means that KGL is currently overvalued and has a potential downside of -1.19%.
Is KGL a buy, sell or hold?
What are the forecasts/targets for the KGL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.6 | 23.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.4 | 7.2% |
KGL Fundamental Data Overview
Market Cap PLN = 97.3m (97.3m PLN * 1.0 PLN.PLN)
CCE Cash And Equivalents = 4.69m PLN (Cash And Short Term Investments, last quarter)
P/S = 0.1854
P/B = 0.7476
Beta = 0.254
Revenue TTM = 524.9m PLN
EBIT TTM = 4.27m PLN
EBITDA TTM = 33.3m PLN
Long Term Debt = unknown (0.0)
Short Term Debt = 75.5m PLN (from shortTermDebt, last quarter)
Debt = 75.5m PLN (Calculated: Short Term 75.5m + Long Term 0.0)
Net Debt = 130.3m PLN (from netDebt column, last quarter)
Enterprise Value = 168.2m PLN (97.3m + Debt 75.5m - CCE 4.69m)
Interest Coverage Ratio = 0.34 (Ebit TTM 4.27m / Interest Expense TTM 12.7m)
FCF Yield = 4.29% (FCF TTM 7.21m / Enterprise Value 168.2m)
FCF Margin = 1.37% (FCF TTM 7.21m / Revenue TTM 524.9m)
Net Margin = -1.47% (Net Income TTM -7.70m / Revenue TTM 524.9m)
Gross Margin = 13.96% ((Revenue TTM 524.9m - Cost of Revenue TTM 451.6m) / Revenue TTM)
Tobins Q-Ratio = 1.73 (Enterprise Value 168.2m / Book Value Of Equity 97.3m)
Interest Expense / Debt = 4.29% (Interest Expense 3.24m / Debt 75.5m)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 0.94 (Total Current Assets 167.4m / Total Current Liabilities 178.3m)
Debt / Equity = 0.59 (Debt 75.5m / last Quarter total Stockholder Equity 127.4m)
Debt / EBITDA = 2.27 (Net Debt 130.3m / EBITDA 33.3m)
Debt / FCF = 10.48 (Debt 75.5m / FCF TTM 7.21m)
Total Stockholder Equity = 130.1m (last 4 quarters mean)
RoA = -2.05% (Net Income -7.70m, Total Assets 375.7m )
RoE = -5.92% (Net Income TTM -7.70m / Total Stockholder Equity 130.1m)
RoCE = 3.29% (Ebit 4.27m / (Equity 130.1m + L.T.Debt 0.0))
RoIC = 2.05% (Ebit 4.27m / (Assets 375.7m - Current Assets 167.4m))
WACC = unknown (E(97.3m)/V(172.9m) * Re(5.55%)) + (D(75.5m)/V(172.9m) * Rd(4.29%) * (1-Tc(none)))
Shares Correlation 5-Years: -70.70 | Cagr: -0.27%
Discount Rate = 5.55% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈21.7m ; Y1≈26.7m ; Y5≈45.6m
Fair Price DCF = 109.9 (DCF Value 775.5m / Shares Outstanding 7.05m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: -84.11 | Revenue CAGR: -12.45%
Rev Growth-of-Growth: 7.98
EPS Correlation: 3.76 | EPS CAGR: -37.54%
EPS Growth-of-Growth: -268.1